Citi tells investors it's time to sell Moderna after 600%-plus stock gains
Moderna Inc MRNA
News
Moderna will reveal the data for its mRNA cancer vaccine next month. Here's why it matters.
23 best-performing stocks of August, as the software industry continues its recovery
23 best-performing stocks of August, as the -2-
FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech, Novavax — Update
FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech
Moderna to Sell $2 Billion Convertible Notes in Private Placement
The Treasury, the Fed and the threat to your -2-
The Treasury, the Fed and the threat to your money
Moderna's personalized mRNA shot could reshape the fight against skin cancer - but it may also be overhyped
Moderna's cancer-vaccine breakthrough drives broad biopharma stock rally
Moderna's experimental vaccine prevents cancer recurrence, in 'historic' win for personalized medicine. Its stock soared.
Moderna Moves Back Toward Covid-Era Valuation With Latest mRNA Update
Moderna, Merck Shares Rally After Trial Shows Vaccine Success in Preventing Melanoma From Returning
Arbutus Files More Patent Infringement Suits Against Pfizer, BioNTech — Update
Arbutus Files More Patent Infringement Suits Against Pfizer, BioNTech
The 20 best-performing stocks in the S&P 500 for the first half of 2026
Healthcare stocks have become a haven for investors ditching tech
FDA Votes in Favor of Benefit-Risk Profile for Moderna's Flu Vaccine
FDA to Hold Review Meeting for Moderna's Flu Vaccine
United States